🔴 Citius Pharmaceuticals is trading 7.5% down today on profit-taking after LYMPHIR rally

Citius Pharmaceuticals is trading 7.5% down now at $0.72 after profit-taking and consolidation following a sharp LYMPHIR-driven rally.

• Shares gained 25.45% to $0.78 on August 5.
• Recent LYMPHIR updates highlighted broader commercial deployment and expanding market adoption, with nationwide field operations expected during August 2026.
• Healthcare-sector strength does not explain the company-specific decline, which does not appear tied to a newly reported negative catalyst.